Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos (NCT05697068)
Tailored Behavioral Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos
🩺 Plain-English Summary (8th-Grade Level)
This study will examine the effectiveness of a 6-week behavioral intervention for patients who are recently diagnosed with COVID-19. Patients and their households will be randomized to one of two groups (Standard of Care vs. Enhanced Standard of Care). Patients in the Standard-of-Care group will receive established clinical care and follow-up. Patients in the Enhanced Standard-of-Care group will receive standard-of-care plus tailored, real-time text messaging and virtual counseling delivered by promotores/as. The investigators hypothesize that households in the Enhanced Standard-of-Care group will have fewer (any new) household COVID-19 infectivity rates compared to households in the standard-of-care group post-intervention.
Who can join: Review the eligibility criteria below.
Location: San Diego State University Research Foundation — San Diego, California
Age range: 18 Years
🧪 Interventions in This Study
- COVID Prevention Program (CPP) (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- San Diego State University Research Foundation — San Diego, California
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in SARS-CoV-2 Infection
- Understanding the Long-term Impact of COVID on Children and Families — Birmingham, Alabama
- Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults — Birmingham, Alabama
- T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients — Washington D.C., District of Columbia
Explore by condition: All SARS-CoV-2 Infection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.